Abstract: Specifically, a dry corn fractionation system which operates to produce an endosperm fraction which can be concurrently of greater purity at greater yield than obtainable from corn milling or dry corn milling processes.
Type:
Application
Filed:
October 8, 2013
Publication date:
February 6, 2014
Applicant:
MOR Technolgogy, LLC
Inventors:
Kenneth E. DeLine, Daniel L. Claycamp, Daniel Fetherston, Rodger T. Marentis
Abstract: There is provided in accordance with an exemplary embodiment of the invention a method for monitoring or training in ultrasound guided procedures. There is also provided in accordance with an exemplary embodiment of the invention a pregnant woman simulator for simulating ultrasound guided procedures.
Abstract: A system for training practitioners in use of an ultrasound system including a unit for managing workflow of an ultrasound training session, a user interface for providing ultrasound training session instructions to a practitioner operating an ultrasound machine and for receiving input from a trainee, a unit for communication with the ultrasound machine, for collecting one or more ultrasound images produced during the training session from the ultrasound machine, a unit for image processing the ultrasound images, and a unit for assessing quality of the ultrasound images. A method for monitoring practitioner proficiency in use of an ultrasound system including providing the practitioner with an ultrasound task definition, collecting one or more ultrasound images produced by the practitioner during performance of the ultrasound task from an ultrasound machine, image processing the ultrasound images, and assessing quality of the ultrasound images. Related apparatus and methods are also described.
Abstract: The invention provides a method and a composition for the treatment of infants age less than 2.5 years old defined as small for gestational age (SGA), including the use of hGH or any compound that increases blood levels of hGH or of IGF-I. Early use of the composition prevents the irreversible neurological and psychological damage of the children.
Abstract: A method for repairing a perforation in a tympanic membrane comprising attaching a single patch to an undersurface of the tympanic membrane covering the perforation.
Abstract: Supercritical carbon dioxide extraction of corn germ oil from corn germ utilizing extraction conditions adapted to a dry corn fractionation ethanol production process.
Type:
Grant
Filed:
October 28, 2009
Date of Patent:
December 10, 2013
Assignee:
MOR Supercritical, LLC
Inventors:
Kenneth E. DeLine, Daniel L. Claycamp, Daniel Fetherston, Rodger T. Marentis
Abstract: The present invention provides methods and compositions for identifying subjects at risk of developing a complication of pregnancy, such as preeclampsia or preterm labor. The compositions are microRNAs and associated nucleic acids.
Type:
Grant
Filed:
January 26, 2009
Date of Patent:
November 12, 2013
Assignees:
Rosetta Genomics Ltd., Mor Research Applications
Abstract: A method of preventing and/or treating S. pneumoniae infection in mammalian subjects, wherein said method comprises administering to said subjects a composition comprising one or more agents that are capable of inhibiting the binding of the S. pneumoniae cell wall protein FBA to the respiratory tract cells of said subject.
Type:
Grant
Filed:
September 29, 2008
Date of Patent:
November 5, 2013
Assignees:
Ben-Gurion University of the Negev Research and Development Authority, Mor Research Applications Ltd.
Abstract: Generally, a method of pressure regulated supercritical fluid fractionation of oil seed extraction materials which can be utilized to refine oil seed extraction material established in an amount of supercritical fluid. Specifically, a method of pressure regulated supercritical fluid fractionation of corn germ extraction material to produce a refined corn oil extraction material.
Abstract: Specifically, a dry corn fractionation system which operates to produce an endosperm fraction which can be concurrently of greater purity at greater yield than obtainable from corn milling or dry corn milling processes.
Type:
Grant
Filed:
July 23, 2012
Date of Patent:
October 8, 2013
Assignee:
MOR Technology, LLC
Inventors:
Kenneth E. DeLine, Daniel L. Claycamp, Daniel Fetherston, Rodger T. Marentis
Abstract: A material handling apparatus is described including a vehicle having a front end, a rear end, a left side, a right side, a chassis, and a ground engagement device attached to the chassis for providing movement of the vehicle across ground; an engine constructed for propelling the vehicle; a loader assembly; a hydraulic system constructed for driving the loader assembly; and operator area including a cage for protecting an operator located within the operator area, and controls for controlling movement of the vehicle and for controlling operation of the loader assembly; and a forward tools area extending from the operator seating area to the front end of the vehicle. The material handling apparatus can include an entrance to the operator area through the rear end of the vehicle, a loader assembly that includes a tower that rotates relative to the chassis, and a dump box or work platform provided in the forward tools area. A method for operating a material handling apparatus is provided.
Abstract: A chitosan composition which forms a hydrogel at near physiological pH and 37° C., comprising at least one type of chitosan having a degree of acetylation in the range of from about 30% to about 60%, and at least one type of chitosan having a degree of deacetylation of at least about 70% is disclosed. Further disclosed is a chitosan composition which forms a hydrogel at near physiological pH and 37° C., that includes at least one type of chitosan having a degree of deacetylation of at least about 70% and a molecular weight of from 10-4000 kDa, and at least one type of a chitosan having a molecular weight of from 200-20000 Da. Further disclosed are methods of preparation and uses of the chitosan compositions.
Type:
Application
Filed:
March 14, 2013
Publication date:
September 19, 2013
Applicant:
MOR RESEARCH APPLICATIONS LTD.
Inventors:
Noah Ben-Shalom, Zvi Nevo, Abraham Patchornik, Dror Robinson
Abstract: A method of analysis is disclosed. The method comprises: registering a target image to define a plurality of keypoints arranged in sets corresponding to polygons or linear segments in the target image; accessing a database of registered and annotated images, and employing a polygon-wise comparison between the target image and each database image; and using the comparison for projecting annotated locations from the database images into the target image.
Type:
Application
Filed:
March 14, 2013
Publication date:
August 22, 2013
Applicants:
Ramot at Tel-Aviv University Ltd., Mor Research Applications Ltd.
Inventors:
Mor Research Applications Ltd., Ramot at Tel-Aviv University Ltd.
Abstract: An ocular implant including a hydrophobic pseudo-endothelial implant and a binding agent applied thereto, the binding agent capable of bonding the implant to a posterior portion of a cornea such that the implant serves as a water barrier enabling dehydration of the cornea.
Abstract: The present invention relates to prognostic methods and kits for the assessment and monitoring of relapse-free or disease-free survival of ALL patients. The detection is based on the use of detecting nucleic acids, specific for determination of the expression of at least one of miR-151-5p and miR-451 in a test sample. The invention thereby also provides methods and kits for monitoring and early diagnosis of cancerous disorders associated with low miR-151-5p and/or miR-451 expression, specifically ALL.
Abstract: The present invention provides combinations of an antipsychotic drug and a tetracycline, particularly minocycline, for the treatment of psychotic disorders, particularly schizophrenia. The invention also provides formulations wherein the release of one or both of the antipsychotic drug and the tetracycline is modified. The invention also provides methods using the combined therapy for treatment of psychotic disorders, particularly schizophrenia, comprising an antipsychotic drug and a tetracycline.
Abstract: This invention is directed, inter alia, to methods and kits for rapid, easy and cost-effective methods of breast cancer prediction and diagnosis in inter alia, blood samples.
Type:
Application
Filed:
October 24, 2012
Publication date:
July 25, 2013
Applicants:
Mor Research Application Ltd., Ben Gurion University of the Negev Research and Development Authority
Inventors:
Ben Gurion University of the Negev Research and, Mor Research Application Ltd.
Abstract: An embodiment of the invention provides a method of diagnosing obstructive sleep apnea, the method comprising: acquiring a sleep sound signal comprising sounds made by a person during sleep; detecting a plurality of snore sounds in the sleep sound signal; determining a set of mel-frequency cepstral coefficients for each of the snore sounds; determining a characterizing feature for the sleep sound signal responsive to a sum of the variances of the cepstral coefficients; and using the characterizing feature to diagnose obstructive sleep apnea in the person.
Type:
Application
Filed:
August 24, 2011
Publication date:
July 18, 2013
Applicants:
MOR RESEARCH APPLICATIONS LTD., BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
Inventors:
Yaniv Zigel, Ariel Tarasiuk, Nir Ben Israel
Abstract: The present: invention reveals a strong correlation between FGL-2 prothrombinase activity levels and the presence of a malignant proliferative disorder in a subject. Thus, the present invention provides FGL-2 prothrombinase activity as a diagnostic tool for malignancy.
Type:
Application
Filed:
July 11, 2011
Publication date:
May 9, 2013
Applicants:
RAMOT AT TEL-AVIV UNIVERSITY LTD., MOR RESEARCH APPLICATIONS LTD.
Abstract: Antisense oligonucleotides against cPLA2 are provided, which are capable of inhibiting cPLA2 expression as well as superoxide production, especially in phagocytes. These antisense oligonucleotides are powerful agents for the treatment of inflammatory conditions, in particular arthritis, as well as in neurodegenerative diseases. The antisense oligonucleotides or compositions comprising the same may be used in methods of treatment of such diseases.
Type:
Application
Filed:
July 12, 2012
Publication date:
November 1, 2012
Applicants:
Ben Gurion University of the Negev Research and Development Authority, Mor Research Applications Ltd.